Cargando…

CD38: T Cell Immuno-Metabolic Modulator

Activation and subsequent differentiation of T cells following antigenic stimulation are triggered by highly coordinated signaling events that lead to instilling cells with a discrete metabolic and transcriptional feature. Compelling studies indicate that intracellular nicotinamide adenine dinucleot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kar, Anwesha, Mehrotra, Shikhar, Chatterjee, Shilpak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408359/ https://www.ncbi.nlm.nih.gov/pubmed/32709019 http://dx.doi.org/10.3390/cells9071716

Ejemplares similares

CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019)

Dynamic Metabolism in Immune Response
por: Al-Hommrani, Mazen, et al.
Publicado: (2016)

Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8(+) T Cells
por: Chowdhury, Snehanshu, et al.
Publicado: (2022)

Interferon-Gamma (IFN-γ)-Mediated Retinal Ganglion Cell Death in Human Tyrosinase T Cell Receptor Transgenic Mouse
por: Husain, Shahid, et al.
Publicado: (2014)

NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
por: Zambello, Renato, et al.
Publicado: (2020)

Deletion of Pim Kinases Elevates the Cellular Levels of Reactive Oxygen Species and Sensitizes to K-Ras-Induced Cell Killing
por: Song, Jin H., et al.
Publicado: (2014)

Immuno-targeting the multifunctional CD38 using nanobody
por: Li, Ting, et al.
Publicado: (2016)

Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta
por: Kang, In-Hong, et al.
Publicado: (2022)

Immuno-Metabolic Modulation of Liver Oncogenesis by the Tryptophan Metabolism
por: Trézéguet, Véronique, et al.
Publicado: (2021)

CCL22 to activate Treg migration and suppress depigmentation in vitiligo
por: Eby, Jonathan M., et al.
Publicado: (2015)

Hematopoietic Stem Cells as a Novel Source of Dental Tissue Cells
por: Wilson, Katie R., et al.
Publicado: (2018)

Intratumoral PD1(+)CD38(+)Tim3(+) CD8(+) T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer
por: Basak, Debashree, et al.
Publicado: (2023)

Sirtuins and Immuno-Metabolism of Sepsis
por: Wang, Xianfeng, et al.
Publicado: (2018)

A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo
por: Chatterjee, Shilpak, et al.
Publicado: (2013)

(89)Zr-DFO-Isatuximab for CD38-Targeted ImmunoPET Imaging of Multiple Myeloma and Lymphomas
por: Herrero Alvarez, Natalia, et al.
Publicado: (2023)

Concepts for agonistic targeting of CD40 in immuno-oncology
por: Richards, David M., et al.
Publicado: (2019)

Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control
por: Kesarwani, Pravin, et al.
Publicado: (2016)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Macrophages, Meta-Inflammation, and Immuno-Metabolism
por: Shapiro, Haim, et al.
Publicado: (2011)

An Update on the Role of Leptin in the Immuno-Metabolism of Cartilage
por: Cordero-Barreal, Alfonso, et al.
Publicado: (2021)

Elevated number of IL-21+ TFH and CD86+CD38+ B cells in blood of renal transplant recipients with AMR under conventional immuno-suppression
por: Liu, Jing, et al.
Publicado: (2022)

New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy
por: Oberholtzer, Nathaniel, et al.
Publicado: (2022)

The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases
por: DeMaio, Alexa, et al.
Publicado: (2022)

CD38 in Neurodegeneration and Neuroinflammation
por: Guerreiro, Serge, et al.
Publicado: (2020)

The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors
por: Konen, Jessica M., et al.
Publicado: (2019)

Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
por: Giannone, Gaia, et al.
Publicado: (2020)

Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity
por: Chakraborty, Paramita, et al.
Publicado: (2019)

CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
por: Hashimoto, Kenji
Publicado: (2021)

Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017)

The role of CD38 in HIV infection
por: Lu, Liqi, et al.
Publicado: (2021)

CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents
por: Costa, Federica, et al.
Publicado: (2019)

CD38 and Regulation of the Immune Response Cells in Cancer
por: Dwivedi, Sanyog, et al.
Publicado: (2021)

Immuno-Modulation of Hematopoietic Stem and Progenitor Cells in Inflammation
por: Sezaki, Maiko, et al.
Publicado: (2020)

Modulation of the Tumor-Associated Immuno-Environment by Non-Invasive Physical Plasma
por: Förster, Sarah, et al.
Publicado: (2023)

Single-Cell Analysis in Immuno-Oncology
por: Christodoulou, Maria-Ioanna, et al.
Publicado: (2023)

Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma
por: Nisnboym, Michal, et al.
Publicado: (2023)

The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research
por: Kitada, Munehiro, et al.
Publicado: (2023)

Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38(+) tumors in mouse models in vivo
por: Fumey, William, et al.
Publicado: (2017)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance
por: Weng, Chao-Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qref15ngv6u81d0l61slsiqsgf